Review

Nature Reviews Microbiology 1, 209-218 (December 2003) | doi:10.1038/nrmicro775

SARS — beginning to understand a new virus

Konrad Stadler1, Vega Masignani1, Markus Eickmann2, Stephan Becker2, Sergio Abrignani1, Hans-Dieter Klenk2 & Rino Rappuoli1  About the authors

Top

The 114-day epidemic of the severe acute respiratory syndrome (SARS) swept 29 countries, affected a reported 8,098 people, left 774 patients dead and almost paralysed the Asian economy. Aggressive quarantine measures, possibly aided by rising summer temperatures, successfully terminated the first eruption of SARS and provided at least a temporal break, which allows us to consolidate what we have learned so far and plan for the future. Here, we review the genomics of the SARS coronavirus (SARS-CoV), its phylogeny, antigenic structure, immune response and potential therapeutic interventions should the SARS epidemic flare up again.

Author affiliations

  1. IRIS, Chiron S.r.l., Via Fiorentina 1, 53100 Siena, Italy.
  2. Institute of Virology, University of Marburg, 35037 Marburg, Germany.

Correspondence to: Rino Rappuoli1 Email: rino_rappuoli@chiron.com

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REFERENCE
Nidoviruses
Nature Encyclopaedia of Life Sciences

RESEARCH
Identification of a new human coronavirus
Nature Medicine Article (01 Apr 2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Nature Letters to Editor (27 Nov 2003)
Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain
The EMBO Journal Article (01 Jul 2002)
See all 4 matches for Research

Extra navigation

Subscribe

Subscribe to Nature Reviews Microbiology

Open Innovation Challenges

natureproducts


Advertisement